Literature DB >> 1722027

Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.

W Dalemans1, P Barbry, G Champigny, S Jallat, K Dott, D Dreyer, R G Crystal, A Pavirani, J P Lecocq, M Lazdunski.   

Abstract

Cystic fibrosis is associated with a defect in epithelial chloride ion transport which is caused by mutations in a membrane protein called CFTR (cystic fibrosis transmembrane conductance regulator). Heterologous expression of CFTR produces cyclicAMP-sensitive Cl(-)-channel activity. Deletion of phenylalanine at amino-acid position 508 in CFTR (delta F508 CFTR) is the most common mutation in cystic fibrosis. It has been proposed that this mutation prevents glycoprotein maturation and its transport to its normal cellular location. We have expressed both CFTR and delta F508 CFTR in Vero cells using recombinant vaccinia virus. Although far less delta F508 CFTR reached the plasma membrane than normal CFTR, sufficient delta F508 CFTR was expressed at the plasma membrane to permit functional analysis. delta F508 CFTR expression induced a reduced activity of the cAMP-activated Cl- channel, with conductance, anion selectivity and open-time kinetics similar to those of CFTR, but with much greater closed times, resulting in a large decrease of open probability. The delta F508 mutation thus seems to have two major consequences, an abnormal translocation of the CFTR protein which limits membrane insertion, and an abnormal function in mediating Cl- transport.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722027     DOI: 10.1038/354526a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  243 in total

Review 1.  Novel pharmacologic therapies for cystic fibrosis.

Authors:  P L Zeitlin
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

Review 2.  Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein.

Authors:  J R Riordan
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

3.  What happens to deltaF508 in vivo?

Authors:  M Drumm
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

Review 4.  Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis.

Authors:  Marina S Gelman; Ron R Kopito
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

5.  Allosteric modulation balances thermodynamic stability and restores function of ΔF508 CFTR.

Authors:  Andrei A Aleksandrov; Pradeep Kota; Liying Cui; Tim Jensen; Alexey E Alekseev; Santiago Reyes; Lihua He; Martina Gentzsch; Luba A Aleksandrov; Nikolay V Dokholyan; John R Riordan
Journal:  J Mol Biol       Date:  2012-03-08       Impact factor: 5.469

6.  A posttranslational modification code for CFTR maturation is altered in cystic fibrosis.

Authors:  Sandra Pankow; Casimir Bamberger; John R Yates
Journal:  Sci Signal       Date:  2019-01-01       Impact factor: 8.192

7.  Direct interaction of a CFTR potentiator and a CFTR corrector with phospholipid bilayers.

Authors:  Debora Baroni; Olga Zegarra-Moran; Agneta Svensson; Oscar Moran
Journal:  Eur Biophys J       Date:  2014-04-26       Impact factor: 1.733

8.  Analysis of cystic fibrosis-associated P67L CFTR illustrates barriers to personalized therapeutics for orphan diseases.

Authors:  Carleen M Sabusap; Wei Wang; Carmel M McNicholas; W Joon Chung; Lianwu Fu; Hui Wen; Marina Mazur; Kevin L Kirk; James F Collawn; Jeong S Hong; Eric J Sorscher
Journal:  JCI Insight       Date:  2016-09-08

9.  Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator.

Authors:  Hal A Lewis; Sean G Buchanan; Stephen K Burley; Kris Conners; Mark Dickey; Michael Dorwart; Richard Fowler; Xia Gao; William B Guggino; Wayne A Hendrickson; John F Hunt; Margaret C Kearins; Don Lorimer; Peter C Maloney; Kai W Post; Kanagalaghatta R Rajashankar; Marc E Rutter; J Michael Sauder; Stephanie Shriver; Patrick H Thibodeau; Philip J Thomas; Marie Zhang; Xun Zhao; Spencer Emtage
Journal:  EMBO J       Date:  2003-12-18       Impact factor: 11.598

Review 10.  Outwardly rectifying chloride channels and CF: a divorce and remarriage.

Authors:  W B Guggino
Journal:  J Bioenerg Biomembr       Date:  1993-02       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.